Why the study?
What is the quality of therapeutic control in patients on oral anticoagulant therapy?
What is the quality of therapeutic control in patients on oral anticoagulant therapy?
A significant proportion of patients on oral anticoagulant therapy fail to maintain target therapeutic ranges, highlighting the need for improved monitoring and control.
Answers are grounded in this paper and cite their sources.
Poor control common especially short-term; leaves open whether enhanced monitoring improves outcomes in prospective studies.
Summary Three hundred and eighty-four patients were studied for up to 1 year while on continuous oral anticoagulant therapy and the quality of control of therapy was assessed. Two hundred and thirty-five patients were on continuous therapy throughout the year (long-term group), 73 were treated for a period between 3 and 12 months (intermediate group) and 76 were treated for less than 3 months (short-term group). The therapeutic objective was to achieve and maintain British Ratio (BR) between 2.0 and 4.0. Nineteen percent of the results in the long-term group, 26.6% in the intermediate group and 41.1% in the short-term group fell outside this range. Among the long-term group only 25.1% and in the intermediate group 12.3% had all their results within the control range. It is concluded that the quality of therapeutic control of oral anticoagulant therapy needs to be improved.
No takes yet. Share an insight, caveat, or question.
Majumdar et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: